Cerecor Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
-
-
-
1,153.00
27,813.10
18,326.80
Cost of Goods Sold (COGS) incl. D&A
20.00
28.90
23.50
-
1,061.10
12,010.70
Gross Income
20.00
28.90
23.50
-
26,752.00
6,316.10
SG&A Expense
12,914.40
17,086.60
10,986.40
17,206.20
12,862.00
24,886
EBIT
12,934.50
17,115.60
11,010.00
16,080.10
13,890.00
18,569.90
Unusual Expense
121.10
2,266.20
1,313.00
72.60
29.60
20,718.90
Interest Expense
-
1,206.20
800.00
464.20
24.00
811.60
Pretax Income
13,045.00
16,055.60
10,490.10
16,471.60
13,836.30
40,086.70
Income Tax
-
-
-
-
1,966.50
33.90
Consolidated Net Income
13,045.00
16,055.60
10,490.10
16,471.60
7,772.10
41,710.20
Net Income
13,045.00
16,055.60
10,490.10
16,471.60
7,772.10
41,710.20
Net Income After Extraordinaries
13,045.00
16,055.60
10,490.10
16,471.60
7,772.10
41,710.20
Net Income Available to Common
13,127.00
3,521.20
10,490.10
16,471.60
7,772.10
41,710.20
EPS (Basic)
1.52
0.41
4.71
1.87
0.42
1.20
Basic Shares Outstanding
8,630.10
8,630.10
2,226.00
8,830.40
18,410.00
34,773.60
EPS (Diluted)
1.52
0.41
4.71
1.87
0.42
1.20
Diluted Shares Outstanding
8,630.10
8,630.10
2,226.00
8,830.40
18,754.80
34,773.60
EBITDA
12,914.40
17,086.60
10,986.40
16,053.20
14,315.50
14,014.90
Non-Operating Interest Income
10.60
-
6.80
-
-
-
Other After Tax Income (Expense)
-
-
-
-
4,097.70
1,657.40
Preferred Dividends
82.00
12,534.40
-
-
-
-

About Cerecor

View Profile
Address
540 Gaither Road
Rockville Maryland 20850
United States
Employees -
Website http://www.cerecor.com
Updated 07/08/2019
Cerecor, Inc. is a clinical stage biopharmaceutical company focuses in medical development. It involves in the discovery, manufacture and commercialization of prescription for neurological and psychiatric disorders. It products include CERC-301, CERC-501, CERC-611, and CERC-406.